Live Breaking News & Updates on இந்தியா தேசிய ஒழுங்குமுறை அதிகாரம்

Stay updated with breaking news from இந்தியா தேசிய ஒழுங்குமுறை அதிகாரம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

NAFDAC Approves AstraZeneca COVID-19 Vaccine for Emergency Use


Onyebuchi Ezigbo in Abuja
The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the emergency use of AstraZeneca as COVID-19 vaccine in Nigeria.
AstraZeneca, from India, is one of the two vaccines received by Nigeria and forwarded to NAFDAC for scientific study.
The other one, Sputnik, developed by Russia, is still being studied by the agency.
NAFDAC’s Director-General, Prof. Mojisola Adeyeye, at a press conference yesterday Abuja said the agency had evaluated the safety and efficacy of the vaccine for Nigerians.
She said the vaccine could be stored in two to eight degrees Centigrade, adding that three more vaccines are being evaluated. ....

South Africa , United Kingdom , Abuja Federal Capital Territory , South African , Astrazeneca Oxford , Mojisola Adeyeye , Onyebuchi Ezigbo , Vaccine Committee , National Agency For Food , Ministry Of Health , Drug Administration , Serum Institute Of India Private Limited , World Health Organisation , Serum Institute Of India On , Nigeria Centre For Disease Control , National Primary Health Care Development Agency , India National Regulatory Authority , National Agency , Serum Institute , Emergency Use Authorisation , India Private Limited , Emergency Use Listing , Use Listing , Nigeria Centre , Disease Control , Global Trade Item Number ,

Official: Why NAFDAC approved Oxford-AstraZeneca coronavirus vaccine


Official: Why NAFDAC approved Oxford-AstraZeneca coronavirus vaccine
February 18, 2021
The National Agency for Food and Drug Administration and Control (NAFDAC) on Thursday approved Oxford AstraZeneca COVID-19 vaccine for use in Nigeria.
The Director-General of the agency, Prof. Mojisola Adeyeye, gave the go ahead for the use of the vaccine at a news conference in Abuja.
She said that the NAFDAC Vaccine Committee commenced expedited review immediately the agency received the Oxford AstraZeneca COVID-19 vaccine dossier from Serum Institute of India on Feb. 10.
She explained that members of the committee worked assiduously to review the vaccine as planned, noting that the recommendation for the emergency use authorisation was based on rigorous scientific consideration. ....

South Africa , United Kingdom , Abuja Federal Capital Territory , South African , Mojisola Adeyeye , Oxford Astrazeneca , Vaccine Committee , Serum Institute Of India On Feb , National Agency For Food , Drug Administration , India National Regulatory Authority , Serum Institute Of India Private Limited , National Agency , Serum Institute , India Private Limited , Med Safety App , Active Pharmacovigilance , Adverse Drug Reactions , ஒன்றுபட்டது கிஂக்டம் , கூட்டாட்சியின் மூலதனம் பிரதேசம் , தடுப்பூசி குழு , சீரம் நிறுவனம் ஆஃப் இந்தியா ஆன் ஃபெப் , இந்தியா தேசிய ஒழுங்குமுறை அதிகாரம் , சீரம் நிறுவனம் ஆஃப் இந்தியா ப்ரைவேட் வரையறுக்கப்பட்டவை , சீரம் நிறுவனம் , இந்தியா ப்ரைவேட் வரையறுக்கப்பட்டவை ,